MT-ND6 and COVID-19: However, studies that quantify N-formylated peptides (e.g. NADH-ubiquinone oxidoreductase chain 6 (ND6)) in COVID-19 patient plasma and assess their relationship with ex vivo neutrophil function are needed to support our hypothesis that mtDAMPs contribute to SARS-CoV-2-induced neutrophil tolerance.